lincomycin has been researched along with edrophonium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Schroeder, LA; Tang, AH | 1 |
| Hashimoto, Y; Iwatsuki, K; Iwatsuki, N; Shima, T | 1 |
1 review(s) available for lincomycin and edrophonium
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for lincomycin and edrophonium
| Article | Year |
|---|---|
The effect of lincomycin on neuromuscular transmission.
Topics: Animals; Chickens; Decamethonium Compounds; Depression, Chemical; Edrophonium; Lincomycin; Muscle Spasticity; Neomycin; Neuromuscular Junction; Penicillin G; Rabbits; Sciatic Nerve; Synaptic Transmission; Tubocurarine | 1968 |
[Neuromuscular relaxing properties of lincomycin and Kanendomycin].
Topics: Calcium Chloride; Curare; Drug Synergism; Edrophonium; Humans; Kanamycin; Lincomycin; Neuromuscular Depolarizing Agents; Succinylcholine | 1971 |